Skip to main content
. 2019 Mar 28;125(14):2474–2487. doi: 10.1002/cncr.32116

Figure 7.

Figure 7

OS of InO‐treated patients who achieved CR/CRi according to follow‐up HSCT. The graph shows the time from randomization to the date of death due to any cause. Patients whose date of death could not be verified were censored at the date of last contact. †One‐sided log‐rank test. CI indicates confidence interval; CR, complete remission; CRi, complete remission with incomplete hematologic recovery; HR, hazard ratio; HSCT, hematopoietic stem cell transplantation; InO, inotuzumab ozogamicin; OS, overall survival.